Alzheon is a biotech company pioneering oral treatments for Alzheimer's and neurological disorders, with ALZ 801 in Phase 3 trials to slow disease progression and prevent symptoms by blocking neurotoxic amyloid formation.
Phone
+1 857-214-7242
Year Founded
2013
